CLINICAL_TRIALS
research
· 2025-08-24
Clinical Trial Update: Does High-dose Vitamin B3 Supplementation Prevent Major Adverse Kidney Events During Septic Shock? [Phase 3]
Summary
This update describes a Phase 3 trial assessing whether high-dose nicotinamide (Vitamin B3) can prevent major adverse kidney events in septic shock patients wit…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Acute Kidney Injury, Septic Shock | Phase 3 | Status: ACTIVE_NOT_RECRUITING